logo-loader
viewMax Petroleum

Max Petroleum needs to strike financing deal to avoid insolvency

us_dollar350_54d86283ccd27.jpg

Max Petroleum (LON:MXP) says it will be insolvent unless it is able to restructure its debts and secure new funding.

The company this morning told investors that a proposed financing deal with AGR Energy will not proceed, and talks with creditor Sberbank have been unsuccessful so far.

“The fall in the oil price since November 2014 has had a very severe adverse impact on the company's current and forecast liquidity position in 2015 and beyond,” the company said in a statement.

Ongoing talks are underway with AGR, over a new financing arrangement, which would comprise both equity-based funding and debt restructuring.

If successful the options under negotiation would render the company viable at current oil prices, Max said.

Nevertheless, the company added that time is running out for a deal to be reached.

“The directors of Max Petroleum currently believe that there is a reasonable prospect that ongoing discussions could result in a sufficient refinancing of the company and, on that basis, have not put the company into administration.”

“However, there is only a short period remaining to achieve such a refinancing and if current efforts are unsuccessful then the consequences will be negative for all stakeholders in the company.”

Quick facts: Max Petroleum

Price: - -

AIM:MXP
Market: AIM
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Admedus Ltd proud to unveil its valves publicly for the first time in London

Admedus Ltd's (ASX:AHZ) CEO Wayne Paterson caught up with Proactive's Andrew Scott while in London. The firm recently made what's been described as a transformational move to sell off its CardioCel® and VascuCel® patch business. Paterson says the focus is now firmly on the Adapt...

2 hours, 15 minutes ago

2 min read